Remove 2026 Remove Equity Financing Remove Finance Remove Technology
article thumbnail

Orchestra BioMedâ„¢ Announces Strategic Collaboration, Closing of $110 Million Private Equity Financing and Plans to List on Nasdaq Through Merger with Health Sciences Acquisitions Corporation 2

Benzinga

Investors in $110 million Series D financing include Medtronic and Terumo as well as lead investor RTW Investments and founding investor Perceptive Advisors. The Series D financing was not contingent on the consummation of the Business Combination. NEW HOPE, Pa. NEW HOPE, Pa.

article thumbnail

3D Systems Reaffirms Commitment to Combination with Stratasys

Benzinga

Complementary Technology Portfolio : Combination of proven technologies with limited overlap, creating a combined portfolio better positioned to service nearly every vertical in the 3D printing market today. Turnaround of a 28-year-old Metals Technology : Full story available on Benzinga.com

EBITDA 40